InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Explore the detailed record of transactions filed by Ronald Sämann, Supervisory Board Member. Officer active across 1 companies, notably RUBIS. Cumulatively, 8 disclosures have been recorded. Total volume traded: €79.9m. The latest transaction was filed on 6 May 2026 — Cession. Regulator: AMF. All data is free.
Declarations8 total
€4m116,248 shares@ €36.43490.17% mcap5.3% of flow
ActionEuronext Access Paris
2026DD1113343·
€17m507,049 shares@ €33.84920.70% mcap22.7% of flow
ActionEuronext Paris
2026DD1108738·
€12m349,709 shares@ €34.23570.49% mcap15.0% of flow
ActionEuronext Paris
2026DD1108651·
€932,09726,475 shares@ €35.20670.038% mcap1.2% of flow
ActionEuronext Paris
2026DD1108239·
€11m300,000 shares@ €35.31060.43% mcap13.3% of flow
ActionEuronext Paris
2026DD1107948·
€21m600,000 shares@ €35.46850.87% mcap26.6% of flow
ActionEuronext Paris
2026DD1107691·
€12m322,016 shares@ €35.71710.47% mcap14.4% of flow
ActionEuronext Paris
2026DD1107292·
€2m100,000 shares@ €22.060.090% mcap2.9% of flow
ActionEuronext Paris
2024DD1012765·
Ideal exit: 3 Aug 2025 (T+270)
8 of 8 declarations
About Ronald Sämann
Ronald Sämann is a governance figure associated with Rubis, where he was proposed and then appointed to the Supervisory Board following the 2024 Annual General Meeting, for a three-year term. His profile combines that of a long-term shareholder and an experienced business leader with a strong orientation toward board dialogue and constructive engagement. Rubis states that he has been a long-standing investor in the company since 2006, with a stake reported at 5.01% of share capital in spring 2024. In April 2026, Rubis announced that he had decided to resign from the Supervisory Board effective 5 May 2026 for personal reasons. Before joining Rubis’ board, Ronald Sämann had already built a track record as an executive with significant international responsibilities. Rubis specifically identifies him as Chairman and Chief Executive Officer of H Young Holdings PLC, and as having held positions in several other companies, including Lakefield Holdings Limited, Rinaldo Rinaldini Ltd, Julius Sämann Ltd, Carissa Ltd, Casinella SA, Wunder-Baum AG, Vestur AG and Julius Sämann AG. His candidacy materials also note that he practiced as a general practitioner and earned a doctorate from the University of Zurich. This unusual blend of medical training, entrepreneurial leadership and international corporate exposure helped shape a profile suited to oversight roles in listed companies. At Rubis, Sämann was presented as a board candidate with broad expertise across international business, M&A, legal matters, HR, compliance, insurance and CSR. His appointment was part of a broader effort to strengthen shareholder dialogue and improve the quality of board work around strategy, governance and long-term value creation. The Board highlighted his active contribution to its work and his status as a loyal long-term shareholder. Overall, Ronald Sämann’s career reflects a combination of entrepreneurial ownership, cross-border management experience and governance engagement, which are highly relevant in a diversified listed group such as Rubis.
